Approval of “GOBIK Aqueous Suspension Syringes”, Pertussis, Diphtheria, Tetanus, Inactivated Polio and Hib Combined Vaccine
March 27, 2023
Mitsubishi Tanabe Pharma Corporation, a member of the Mitsubishi Chemical Group, has announced the following press release.
■Mitsubishi Tanabe Pharma Press Release
Approval of “GOBIK Aqueous Suspension Syringes”, Pertussis, Diphtheria, Tetanus, Inactivated Polio and Hib Combined Vaccine
https://www.mt-pharma.co.jp/e/news/assets/pdf/e_MTPC230327_2.pdf
■Mitsubishi Tanabe Pharma Press Release
Approval of “GOBIK Aqueous Suspension Syringes”, Pertussis, Diphtheria, Tetanus, Inactivated Polio and Hib Combined Vaccine
https://www.mt-pharma.co.jp/e/news/assets/pdf/e_MTPC230327_2.pdf